Human Susceptibility to Visceral Leishmaniasis (<span class='italic'>Leishmania donovani</span>) and to Schistosomiasis (<span class='italic'>Schistosoma mansoni</span>) Is Controlled by Major Genetic Loci

doi:10.1017/CBO9780511546259.011

10 - Human Susceptibility to Visceral Leishmaniasis (Leishmania donovani) and to Schistosomiasis (Schistosoma mansoni) Is Controlled by Major Genetic Loci

Published online by Cambridge University Press: 10 August 2009

A. Dessein ,

L. Argiro ,

S. Marquet ,

H. Dessein ,

S. H. El-Safi and

L. Abel

Edited by

Krishna R. Dronamraju

Show author details

A. Dessein: Affiliation:
Immunology and Genetics of Parasitic Diseases, INSERM, U. 399, Marseille, France
B. Bucheton: Affiliation:
Immunology and Genetics of Parasitic Diseases, INSERM, U. 399, Marseille, France
L. Argiro: Affiliation:
Immunology and Genetics of Parasitic Diseases, INSERM, U. 399, Marseille, France
N. M. A. Elwali: Affiliation:
Institute of Nuclear Medicine and Molecular Biology, University of Gezira, Wad Medani, Sudan
V. Rodrigues: Affiliation:
Laboratory of Immunology, University of Medicine, Triangulo Miniero, Uberaba, Brazil
C. Chevillard: Affiliation:
Immunology and Genetics of Parasitic Diseases, INSERM, U. 399, Marseille, France
S. Marquet: Affiliation:
Immunology and Genetics of Parasitic Diseases, INSERM, U. 399, Marseille, France
H. Dessein: Affiliation:
Immunology and Genetics of Parasitic Diseases, INSERM, U. 399, Marseille, France
S. H. El-Safi: Affiliation:
Institute for Tropical Medicine, PO Box 1304, Khartoum, Sudan
L. Abel: Affiliation:
Laboratory of Human Genetics of Infectious Diseases, INSERM, U. 550, Paris, France
Krishna R. Dronamraju: Affiliation:
Foundation for Genetic Research, Houston, Texas

Book contents

Get access

Summary

SUSCEPTIBILITY TO SEVERE DISEASE DURING AN OUTBREAK OF VISCERAL LEISHMANIASIS IN A SUDANESE VILLAGE

Visceral leishmaniasis (VL) is caused by protozoan parasites of the Leishmania genus that are transmitted to humans by infected sandflies (Figure 10.1a). Parasites rapidly invade host phagocytes and multiply inside phagolysosomes. Clinical disease is primarily due to the uncontrolled multiplication of the parasite in many organs including the spleen and the liver; clinical symptoms include recurrent fever, considerable splenomegaly, hepatomegaly, and adenopathy (1). Death is certain if the patient is left untreated. Violent outbreaks of VL have occurred in regions of eastern Africa (2) (Kenya, Sudan) and in India (Bihar). VL is endemic in South America and in the Mediterranean basin. VL is caused by three Leishmania species: Leishmania donovani, L. chagasi/infantum, and L. archibaldi (L. donovani being the most pathogenic) (3). To identify the principal risk factors in VL, we carried out a five-year longitudinal study on 1,600 subjects from a village located on the Sudanese–Ethiopian border. The study was initiated in 1995 when the number of VL cases had just begun to rise in the village (4). Within five years, 28% of the population had been affected by VL. Most of these VL patients were treated and cured. Unfortunately, a small percentage either failed to respond to treatment or were not treated because of the difficulties involved in reaching them during the rainy season.

Type: Chapter
Information: Infectious Disease and Host-Pathogen Evolution , pp. 241 - 262

DOI: https://doi.org/10.1017/CBO9780511546259.011 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Dessein, A J, Chevillard, C, Marquet, S, Henri, S, Hillaire, D, Dessein, H. 2001. Genetics of parasitic infections. Drug Metab. Dispos. 29(4 Pt 2): 484–8Google Scholar PubMed

Seaman, J, Mercer, A J, Sondorp, E. 1996. The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: Course and impact from 1984 to 1994. Int. J. Epidemiol. 25(4): 862–71CrossRef Google Scholar PubMed

Desjeux P. The increase in risk factors for leishmaniasis worldwide. 2001. Trans. R. Soc. Trop. Med. Hyg. 95: 239–43

El-Safi, S H, Bucheton, B, Kheir, M M, Musa, H A, El-Obeid, M, Hammad, A, and Dessein, A. 2002. Epidemiology of visceral leishmaniasis in Atbara River area, Eastern Sudan: The outbreak of Barbar El Fugara village (1996–1997). Microb. Infect. 14: 1439–47CrossRef Google Scholar

Bucheton B, El-Safi S H, Hammad A, Kheir M M, Eudes N, Mergani A, and Dessein A. 2002. Anti-Leishmania antibodies in an outbreak of visceral leishmaniasis in Eastern Sudan: High antibody responses occur in resistant subjects and are not predictive of disease. Trans. R. Trop. Med. Hyg. (in press)

Lambert, J, and 7 colleagues. 2002. The sand fly fauna in the visceral leishmaniasis focus of Gedaref (Atbara River area, Eastern Sudan). Ann. Trop. Med. Parasitol. 96(6): 631–6CrossRef Google Scholar

Bucheton, B, Kheir, M M, El-Safi, S H, Hammad, A, Mergani, A, Mary, C, Abel, L, and Dessein, A. 2002. The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in Eastern Sudan. Microb. Infect. 14: 1449–57CrossRef Google Scholar

Bradley, D J, Taylor, B A, Blackwell, J, Evans, E P, Freeman, J. 1979. Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. Clin. Exp. Immunol. 37(1): 7–14Google Scholar PubMed

Blackwell, J M. 1996. Genetic susceptibility to leishmanial infections: Studies in mice and man. Parasitology 112(Suppl): S67–S74Google Scholar PubMed

Vidal, S and 9 colleagues. 1995. The Ity/Lsh/Bcg locus: Natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182(3): 655–66CrossRef Google Scholar PubMed

Blackwell, J, Freeman, J, Bradley, D. 1980. Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice. Nature 283(5742): 72–4CrossRef Google Scholar PubMed

Searle, S, Bright, N A, Roach, T I, Atkinson, P G, Barton, C H, Meloen, R H, and colleagues. 1998. Localisation of Nramp1 in macrophages: Modulation with activation and infection. J. Cell. Sci. 111(Pt 19): 2855–66Google Scholar PubMed

Biggs, T E, Baker, S T, Botham, M S, Dhital, A, Barton, C H, Perry, V H. 2001. Nramp1 modulates iron homoeostasis in vivo and in vitro: Evidence for a role in cellular iron release involving de-acidification of intracellular vesicles. Eur. J. Immunol. 31(7): 2060–703.0.CO;2-L>CrossRef Google Scholar PubMed

Blackwell, J M, Goswami, T, Evans, C A, Sibthorpe, D, Papo, N, White, J K, and 5 colleagues. 2001. SLC11A1 (formerly NRAMP1) and disease resistance. Cell Microbiol. 3(12): 773–84CrossRef Google Scholar PubMed

Liu, J, Fujiwara, T M, Buu, N T, Sanchez, F O, Cellier, M, Paradis, A J, and colleagues. 1995. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am. J. Hum. Genet. 56(4): 845–53Google Scholar PubMed

Bellamy, R, Ruwende, C, Corrah, T, McAdam, K P, Whittle, H C, Hill, A V. 1998. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338(10): 640–4CrossRef Google Scholar PubMed

Abel, L, Sanchez, F O, Oberti, J, Thuc, N V, Hoa, L V, Lap, V D, and colleagues. 1998. Susceptibility to leprosy is linked to the human NRAMP1 gene. J. Infect. Dis. 177(1): 133–45CrossRef Google Scholar PubMed

Greenwood, C M, Fujiwara, T M, Boothroyd, L J, Miller, M A, Frappier, D, Fanning, E A, and colleagues. 2000. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am. J. Hum. Genet. 67(2): 405–16CrossRef Google Scholar

Searle, S, Blackwell, J M. 1999. Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J. Med. Genet. 36(4): 295–9Google Scholar PubMed

Bucheton, B, Abel, L, Kheir, M M, Mirghani, A, El-Safi, S, Chevillard, C, Dessein, A. 2003. Genetic control of visceral leishmaniasis in a Sudanese population: Candidate gene testing indicates a linkage to the NRAMP1 gene. Genes. Immun. 4: 104–109CrossRef Google Scholar

Abel, L, Muller-Myhsok, B. 1998. Robustness and power of the maximum-likelihood-binomial and maximum-likelihood-score methods, in multipoint linkage analysis of affected-sibship data. Am. J. Hum. Genet. 63(2): 638–47CrossRef Google Scholar PubMed

Xu, J, Meyers, D A, Ober, C, Blumenthal, M N, Mellen, B, Barnes, K C, and 9 colleagues. 2001. Genomewide screen and identification of gene-gene interactions for asthma-susceptibility loci in three U.S. populations: Collaborative study on the genetics of asthma. Am. J. Hum. Genet. 68(6): 1437–46CrossRef Google Scholar

Lichtenberg, F. 1962. Host response to eggs of S. mansoni. I. Granuloma formation in the unsensitized laboratory mouse. Am. J. Pathol. 41: 711–31Google Scholar

Warren, K S, Domingo, E O, Cowan, R B. 1967. Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am. J. Pathol. 51(5): 735–56Google Scholar PubMed

Butterworth, A E, Capron, M, Cordingley, J S, Dalton, P R, Dunne, D W, Kariuki, H C, and 9 colleagues. 1985. Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans. R. Soc. Trop. Med. Hyg. 79(3): 393–408CrossRef Google Scholar PubMed

Dessein, A J, Begley, M, Demeure, C, Caillol, D, Fueri, J, dos Reis, M G, and 3 colleagues. 1988. Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. J. Immunol. 140(8): 2727–36Google Scholar PubMed

Abel, L, Dessein, A. 1991. Genetic predisposition to high infections in an endemic area of Schistosoma mansoni [editorial]. Rev. Soc. Bras. Med. Trop. 24(1): 1–3CrossRef Google Scholar

Dessein, A J, Couissinier, P, Demeure, C, Rihet, P, Kohlstaedt, S, Carneiro-Carvalho, D, and 4 colleagues. 1992. Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni. Immunol. Invest. 21(5): 423–53CrossRef Google Scholar PubMed

Hagan, P, Blumenthal, U J, Dunn, D, Simpson, A J, Wilkins, H A. 1991. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349(6306): 243–5CrossRef Google Scholar PubMed

Rihet, P, Demeure, C E, Bourgois, A, Prata, A, Dessein, A J. 1991. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur. J. Immunol. 21(11): 2679–86CrossRef Google Scholar PubMed

Couissinier, P, Dessein, A J. 1995. Schistosoma-specific helper T cell from subjects resistant to infection by Schistosoma mansoni are ThO/2. Euro. J. Immunol. 25: 2295–302CrossRef Google Scholar

Rodriguez, V, Piper, K, Couissinier-Paris, P, Bacelar, O, Dessein, H, Dessein, A J. 1999. Genetic control of Schistosome infections by SM1 locus of the 5q31-q33 region is linked to differentition of type 2 helper T lymphocytes. Infect. Immun.67, 4689–92Google Scholar

Rihet, P, Demeure, C E, Dessein, A J, Bourgois, A. 1992. Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area. Eur. J. Immunol. 22(8): 2063–70CrossRef Google Scholar PubMed

Demeure, C E, Rihet, P, Abel, L, Ouattara, M, Bourgois, A, Dessein, A J. 1993. Resistance to Schistosoma mansoni in humans: Influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J. Infect. Dis. 168(4): 1000–8CrossRef Google Scholar PubMed

Abel, L, Demenais, F, Prata, A, Souza, A E, Dessein, A. 1991. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni [see comments]. Am. J. Hum. Genet. 48(5): 959–70Google Scholar

Marquet, S, Abel, L, Hillaire, D, Dessein, H, Kalil, J, Feingold, J, and 2 colleagues. 1996. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet. 14(2): 181–4CrossRef Google Scholar PubMed

Muller-Myhsok, B, Stelma, F F, Guisse-Sow, F, Muntau, B, Thye, T, Burchard, G D, and 2 colleagues. 1997. Further evidence suggesting the presence of a locus, on human chromosome 5q31-q33, influencing the intensity of infection with Schistosoma mansoni [letter; comment]. Am. J. Hum. Genet. 61(2): 452–4CrossRef Google Scholar

Marsh, D G, Neely, J D, Breazeale, D R, Ghosh, B, Freidhoff, L R, Ehrlich-Kautzky, E, and colleagues. 1994. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264(5162): 1152–6CrossRef Google Scholar PubMed

Martinez, F D, Solomon, S, Holberg, C J, Graves, P E, Baldini, M, Erickson, R P. 1998. Linkage of circulating eosinophils markers on chromosome 5q. Am. J. Respir. Crit. Care Med. 158: 1739–44CrossRef Google Scholar PubMed

Rioux, J D, Stone, V A, Daly, M J, Cargill, M, Green, T, Nguyen, H, and colleagues. 1998. Familial eosinophiliz maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am. J. Hum. Genet. 63: 1086–94CrossRef Google Scholar PubMed

Warren, K S. 1977. Modulation of immunopathology and disease in schistosomiasis. Am. J. Trop. Med. Hyg. 26(6 Pt 2): 113–9CrossRef Google Scholar PubMed

Chensue, S W, Warmington, K S, Ruth, J, Lincoln, P M, Kunkel, S L. 1994. Cross-regulatory role of interferon-gam ma (IFN-gamma), IL-4 and IL-10 in schistosome egg granuloma formation: The in vivo regulation of activity and inflammation. Clin. Exp. Immunol. 98(3): 395–400CrossRef Google Scholar

Wynn, T A, Morawetz, R, Scharton-Kersten, T, Hieny, S, Morse, H C 3rd, Kuhn, R, and colleagues. 1997. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J. Immunol. 159(10): 5014–23Google Scholar

Grimaud, J A, Borojevic, R. 1977. Chronic human schistosomiasis mansoni. Pathology of the Disse's space. Lab. Invest. 36(3): 268–73Google Scholar PubMed

Gressner, A M, Bachem, M G. 1995. Molecular mechanisms of liver fibrogenesis – A homage to the role of activated fat-storing cells. Digestion 56(5): 335–46CrossRef Google Scholar PubMed

Poli, G. 2000. Pathogenesis of liver fibrosis: Role of oxidative stress. Mol. Aspects Med. 21(3): 49–98CrossRef Google Scholar PubMed

Hoffmann, K F, Cheever, A W, Wynn, T A. 2000. IL-10 and the dangers of immune polarization: Excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J. Immunol. 164(12): 6406–16CrossRef Google Scholar PubMed

Jimenez, S A, Freundlich, B, Rosenbloom, J. 1984. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J. Clin. Invest. 74(3): 1112–6CrossRef Google Scholar PubMed

Duncan, M R, Berman, B. 1985. Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J. Exp. Med. 162(2): 516–27CrossRef Google Scholar

Czaja, M J, Weiner, F R, Eghbali, M, Giambrone, M A, Eghbali, M, Zern, M A. 1987. Differential effects of gamma-interferon on collagen and fibronectin gene expression. J. Biol. Chem. 262(27): 13,348–51Google Scholar PubMed

Czaja, M J, Weiner, F R, Takahashi, S, Giambrone, M A, Meide, P H, Schellekens, H, and 2 colleagues. 1989. Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology 10(5): 795–800CrossRef Google Scholar PubMed

Rockey, D C, Chung, J J. 1994. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: Implications for treatment of hepatic fibrosis. J. Invest. Med. 42(4): 660–70Google Scholar PubMed

Mallat, A, Preaux, A M, Blazejewski, S, Rosenbaum, J, Dhumeaux, D, Mavier, P. 1995. Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 21(4): 1003–10CrossRef Google Scholar PubMed

Roberts, A B, Sporn, M B, Assoian, R K, Smith, J M, Roche, N S, Wakefield, L M, and 2 colleagues. 1986. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83(12): 4167–71CrossRef Google Scholar PubMed

Tiggelman, A M, Boers, W, Linthorst, C, Sala, M, Chamuleau, R A. 1995. Collagen synthesis by human liver (myo)fibroblasts in culture: Evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma. J. Hepatol. 23(3): 307–17Google Scholar PubMed

Tamai, K, Ishikawa, H, Mauviel, A, Uitto, J. 1995. Interferon-gamma coordinately upregulates matrix metalloprotease (MMP)-1 and MMP-3, but not tissue inhibitor of metalloproteases (TIMP), expression in cultured keratinocytes. J. Invest. Dermatol. 104(3): 384–90CrossRef Google Scholar

Mohamed-Ali, Q, Elwali, N E, Abdelhameed, A A, Mergani, A, Rahoud, S, Elagib, K E, and 3 colleagues. 1999. Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: Evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. J. Infect. Dis. 180(4): 1298–306CrossRef Google Scholar PubMed

Henri, S, Chevillard, C, Mergani, A, Paris, P, Gaudart, J, Camilla, C, and colleagues. 2002. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J. Immunol. 169(2): 929–36CrossRef Google Scholar

Dessein, A J, Hillaire, D, Elwali, E N M A, Marquet, S, Mohamed-Ali, Q, Mirghani, A, and colleagues. 1999. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-g receptor gene. Am. J. Hum. Genet. 68: 709–21CrossRef Google Scholar

Salam, E A, Ishaac, S, Mahmoud, A A. 1979. Histocompatibilty-linked susceptibility for hepatosplenomegaly in human schistosomiasis mansoni. J. Immunol. 123(4): 1829–31Google Scholar PubMed

Abaza, H, Asser, L, el Sawy, M, Wasfy, S, Montaser, L, Hagras, M, and 3 colleagues. 1985. HLA antigens in schistosomal hepatic fibrosis patients with haematemesis. Tissue Antigens 26(5): 307–9CrossRef Google Scholar PubMed

Abdel-Wahab, M F, Esmat, G, Narooz, S I, Yosery, A, Struewing, J P, Strickland, G T. 1990. Sonographic studies of school children in a village endemic for Schistosoma mansoni. Trans. R. Soc. Trop. Med. Hyg. 84(1): 69–73CrossRef Google Scholar

Secor, W E, del Corral, H, dos Reis, M G, Ramos, E A, Zimon, A E, Matos, E P, and colleagues. 1996. Association of hepatosplenic schistosomiasis with HLA-DQB1*0201. J. Infect. Dis. 174(5): 1131–5CrossRef Google Scholar PubMed

Casanova, J L, Abel, L. 2002. Genetic dissection of immunity to mycobacteria: The human model. Annu. Rev. Immunol. 20: 581–620.CrossRef Google Scholar PubMed

Book contents

10 - Human Susceptibility to Visceral Leishmaniasis (Leishmania donovani) and to Schistosomiasis (Schistosoma mansoni) Is Controlled by Major Genetic Loci

Summary

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive